New York, NY (PRWEB) December 07, 2013
The birth control safety center at DrugNews.net is announcing updated information for women who took the drugs Yaz or Yasmin in recent years. New court records show lawsuits alleging the drug caused side effects is dwindling as the drug’s maker settles thousands of cases*.
DrugNews is designed to improve the safety of those taking popular prescription drugs by providing the latest safety alerts, recalls, studies and legal news. Patients can avoid potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added warnings from health experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots.
To accommodate the number of women who filed a Yaz lawsuit alleging side effects, cases were consolidated to a special federal Multi-District Litigation court. (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
DrugNews has added information showing Bayer, the maker of Yaz, has already spent around $1.575 billion to settle approximately 7,660 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)****.
Now, the resource center has learned the latest court records show the number of claims still pending has dropped slightly from 9,873 on October 17th to 9,837 as of November 18*.
Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugNews Center or speak with a lawyer about their options under the current settlement.
Due to the complexity of drug injury cases, patients should seek a lawyer with experience in defective drug litigation. DrugNews only recommends lawyers who have already settled Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*JPML 11/18/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-November-18-2013.pdf
**BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****Bayer Stockholder’s Newsletter, Explanatory Notes; Legal Risks, 10/31/13; stockholders-newsletter-q3-2013.bayer.com/en/explanatory-notes.aspx